ID   WM1617
AC   CVCL_6791
SY   WM-1617; WM 1617; WC00076
DR   cancercelllines; CVCL_6791
DR   Coriell; WC00076
DR   Cosmic; 686409
DR   GEO; GSM109029
DR   GEO; GSM952583
DR   Progenetix; CVCL_6791
DR   Wikidata; Q54994186
RX   PubMed=2253310;
RX   PubMed=16827748;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; 9588; PTEN; Zygosity=Hemizygous (from autologous cell line WM278).
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=16827748).
CC   Omics: Transcriptome analysis by microarray.
CC   Discontinued: Coriell; WC00076; probable.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6473 ! WM278
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 25
//
RX   PubMed=2253310; DOI=10.1007/BF00046337;
RA   Herlyn M.;
RT   "Human melanoma: development and progression.";
RL   Cancer Metastasis Rev. 9:101-112(1990).
//
RX   PubMed=16827748; DOI=10.1111/j.1600-0749.2006.00322.x;
RA   Hoek K.S., Schlegel N.C., Brafford P., Sucker A., Ugurel S., Kumar R.,
RA   Weber B.L., Nathanson K.L., Phillips D.J., Herlyn M., Schadendorf D.,
RA   Dummer R.;
RT   "Metastatic potential of melanomas defined by specific gene expression
RT   profiles with no BRAF signature.";
RL   Pigment Cell Res. 19:290-302(2006).
//